NCT01277705View on ClinicalTrials.gov

Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®

PHASE3CompletedINTERVENTIONAL
Enrollment

806

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
TetanusDiphtheriaAcellular Pertussis
Interventions
BIOLOGICAL

GSK Biologicals' reduced antigen diphtheria and tetanus toxoids and acellular pertussis- inactivated poliovirus vaccine

Intramuscular, single

BIOLOGICAL

Boostrix™

Intramuscular, single dose

BIOLOGICAL

GSK Biologicals' IPV vaccine

Intramuscular, single dose

BIOLOGICAL

Revaxis®

Intramuscular, single dose

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY